Sentinel lymph node melanoma metastases: Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)

Hojabr Kakavand, Ricardo E. Vilain, James S. Wilmott, Hazel Burke, Jennifer H. Yearley, John F. Thompson, Peter Hersey, Georgina V. Long, Richard A Scolyer

Article2012

Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases

Stephen S. Koh, Jia-Perng Jennifer Wei, Xinmin Li, Rong Huang, Ngan Doan, Richard A Scolyer, Alistair J. Cochran, Scott W. Binder

Article2015

Detailed Pathological Examination of Completion Node Dissection Specimens and Outcome in Melanoma Patients with Minimal (<0.1 mm) Sentinel Lymph Node Metastases

Lodewijka H. J. Holtkamp, Shu Wang, James S. Wilmott, Jason Madore, Ricardo E. Vilain, John F. Thompson, Omgo E. Nieweg, Richard A Scolyer

Article2013

The prognostic significance of sentinel node tumour burden in melanoma patients: An international, multicenter study of 1539 sentinel node-positive melanoma patients

Augustinus P. T. van der Ploeg, Alexander C.J. van Akkooi, Lauren E. Haydu, Richard A Scolyer, Rajmohan Murali, Cornelis Verhoef, John F. Thompson, Alexander M.M. Eggermont

Sentinel lymph node melanoma metastases: Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)

Discussion(0)

Related publications

Sentinel Lymph Node Biopsy for Melanoma: Aspects of Pathologic Assessment

Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases

Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases

Detailed Pathological Examination of Completion Node Dissection Specimens and Outcome in Melanoma Patients with Minimal (&lt;0.1 mm) Sentinel Lymph Node Metastases

The prognostic significance of sentinel node tumour burden in melanoma patients: An international, multicenter study of 1539 sentinel node-positive melanoma patients

Detailed Pathological Examination of Completion Node Dissection Specimens and Outcome in Melanoma Patients with Minimal (<0.1 mm) Sentinel Lymph Node Metastases